This announcement is a separate document:
华仁药业：关于低钙腹膜透析液（乳酸盐-G1.5%、G2.5%、G4.25%）取得药品补充申请批准通知书的公告
Huaren Pharmaceutical: Notice on Obtaining Approval Notice for Low-Calcium Peritoneal Dialysis Solution (Lactate-G 1.5%, G 2.5%, G 4.25%)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated